Pancreatic Stone Protein Testing Market Set to Reach USD 3.59 Billion by 2032, Growing at a CAGR of 1.8%

Pancreatic Stone Protein Testing Market
Pancreatic Stone Protein Testing Market

The pancreatic stone protein (PSP) testing market is poised for steady growth, currently valued at USD 3 billion in 2022 and projected to reach approximately USD 3.59 billion by 2032. This growth represents a compound annual growth rate (CAGR) of 1.8% during the forecast period.

Pancreatic stone protein testing is essential in diagnosing and managing various pancreatic disorders, offering valuable insights into patient health and treatment efficacy. As the prevalence of pancreatic diseases continues to rise, the demand for accurate and reliable testing methods is becoming increasingly critical.

Key Market Drivers:

  • Rising Incidence of Pancreatic Disorders: The growing prevalence of conditions such as pancreatitis and pancreatic cancer is driving the demand for pancreatic stone protein testing, as early diagnosis is vital for effective treatment.
  • Advancements in Testing Technologies: Ongoing innovations in testing methodologies are enhancing the accuracy and efficiency of PSP tests, making them more accessible to healthcare providers and patients alike.
  • Increased Awareness: Greater awareness of pancreatic health and the importance of early detection is contributing to the market’s growth, as both healthcare professionals and patients seek better diagnostic tools.
  • Healthcare Infrastructure Improvements: As healthcare systems continue to evolve, investments in laboratory infrastructure and diagnostic capabilities are expected to further boost the market for pancreatic stone protein testing.

A life-threatening syndrome is known as Sepsis resulting in multiple organ dysfunction. That is characterized by the deregulated host response to an infection. According to WHO sepsis affects more than 30 million people worldwide every year. Leading to 6 million deaths.

The occurrence of sepsis is most likely highest in low- and middle-income countries.  However, for the diagnosis of sepsis, pancreatic stone protein testing is showing great promises. Pancreatic stone protein has been used as a marker for the early detection and diagnosis of sepsis. Also, pancreatic stone protein has been used as a novel protein biomarker for the diagnosis of several other diseases related to pancreatic stone formation due to infection.

Pancreatic stone protein testing is also helping in early diagnosis and management of diseases such as acute appendicitis and other wolfram syndromes such as diabetes insipidus, diabetes mellitus, optic atrophy etc.

Global Pancreatic Stone Protein Testing Industry: Driver and Restraints

The increasing cases of chronic diseases due to pancreatic stone formation expected to drive the market of pancreatic stone protein testing. The prevalence of diseases such as acute appendicitis, diabetes and optic atrophy drives the pancreatic stone protein testing market worldwide.

Change in lifestyle, increasing consumption of alcohol promotes acute pancreatitis, which expected to drive the pancreatic stone protein testing market.

However, the symptoms of acute pancreatitis are nonspecific and biomarker such as pancreatic stone protein testing is high sensitivity and specificity are still lacking despite extensive research.

Further, the cost-effectiveness, sensitivity, accuracy, and specificity of the pancreatic stone protein testing expected to restrain the pancreatic stone protein testing market.

Global Pancreatic Stone Protein Testing Industry: Overview

The market of pancreatic stone protein testing is very demanding globally because of its importance of used as a biomarker for the early detection of various life-threatening diseases. The symptoms of acute pancreatitis rate are higher in developing countries as well as in developed countries.

Due to the change in lifestyles, irregular and unhealthy food consumption develops diseases such as sepsis, acute appendicitis and Wolfram syndrome worldwide. Consequently, the global market of pancreatic stone protein testing will expectedly grow vigorously in the near forecasting periods.

The global key players have immense opportunities to develop assay kits and other immunoassay devices for the evaluation of pancreatic stone protein testing.

Global Pancreatic Stone Protein Testing Industry: Region-wise Outlook

North America is expected as the leading market of pancreatic stone protein testing due to a greater degree of awareness among the individuals and high economy followed by Europe.

Moderate growth of the Global Pancreatic Stone Protein Testing Industry will be expected in Asia Pacific countries due to the increasing rate of sepsis, acute appendicitis diseases and awareness among the people.

Global Pancreatic Stone Protein Testing Industry: Key Market Participants

Ray Biotech, Inc., Thermo Fisher Scientific, Inc. Lifespan Biosciences Inc., Abnova Corporation, Amsbio LLC. (AMS Biotechnology (Europe) Ltd), CUSABIO TECHNOLOGY LLC, Boster Biological Technology, United States Biological Inc., Creative Diagnostics Inc., Abbexa Ltd., Aviva Systems Biology Corporation, among others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.

The research report provides analysis and information according to market segments such as geographies, application, and industry.

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, China ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Global Pancreatic Stone Protein Testing Industry: Segmentation

Based on techniques used, Global Pancreatic Stone Protein Testing Industry can be segmented as:

  • ELISA
  • Fluorometric Immunoassay

Based on Disease types, Global Pancreatic Stone Protein Testing Industry can be segmented as:

  • Sepsis
  • Acute Appendicitis
  • Diabetes
  • Diabetes Insipidus
  • Diabetes Mellitus
  • Optic Atrophy
  • Deafness

Based on the age group, Global Pancreatic Stone Protein Testing Industry can be segmented as:

  • Infant
  • Children
  • Adults
  • Geriatric

Based on end-users, the Global Pancreatic Stone Protein Testing Industry can be segmented as:

  • Hospitals
  • Speciality Clinics
  • Diagnostic Centers
  • Pathology Laboratories

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Peptide Receptor Radionuclide Therapy (PRRT) Market Set to Reach USD 1,300 Million by 2033, Growing at a CAGR of 8.2%

Peptide Receptor Radionuclide Therapy (PRRT) Market
Peptide Receptor Radionuclide Therapy (PRRT) Market

The peptide receptor radionuclide therapy (PRRT) market is projected to be valued at approximately USD 591.83 million in 2023 and is expected to expand significantly, reaching USD 1,300 million by 2033. This growth reflects a robust compound annual growth rate (CAGR) of 8.2% during the forecast period from 2023 to 2033.

PRRT is emerging as a transformative treatment for neuroendocrine tumors, harnessing the power of targeted radionuclide therapy to improve patient outcomes. Several key trends are propelling the growth of the PRRT market:

  • Innovative Approaches: Novel PRRT strategies, including combination therapies and the use of alternative radionuclides, are capturing the attention of researchers and healthcare professionals. These advancements aim to enhance treatment efficacy and provide more options for patients.
  • Enhanced Diagnostics: The integration of improved diagnostic tools is playing a crucial role in the precise selection of patients for PRRT, enabling healthcare providers to optimize treatment planning and outcomes.
  • Data Analytics and AI: The incorporation of data analytics and artificial intelligence in PRRT is revolutionizing treatment customization, offering more tailored patient care strategies and improving overall effectiveness.
  • Telemedicine Integration: The rise of telemedicine consultations and follow-ups is enhancing accessibility and patient engagement in PRRT, ensuring that patients receive timely care and support regardless of their location.
  • Advocacy and Awareness: The growing presence of patient advocacy groups is significantly impacting the PRRT landscape. These organizations are raising awareness about treatment options, influencing healthcare policies, and driving research efforts in the field.

Advancement and growing researches in the medical industry leads to a dramatic surge in the availability of new cancer treatment options. Radiation therapies and targeted therapy is showing significant promise in cancer treatment. For example, peptide receptor radionuclide therapy (PRRT) had recently approved the neuroendocrine tumors and projecting significant growth in the cancer treatment market. Peptide receptor radionuclide therapy (PRRT) is radioisotope or molecular therapy used to treat neuroendocrine tumors (NETs).

Peptide receptor radionuclide therapy (PRRT) is recommended for the somatostatin receptor-positive gastroenteropancreatic NETs affected patients. Peptide receptor radionuclide therapy (PRRT) is a targeted therapy designed to slow the progression of gastroenteropancreatic NET and limiting radiation exposure to healthy tissue. Lutathera (lutetium Lu 177 Oxodotreotide) was the first drug approved for the peptide receptor radionuclide therapy (PRRT) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In September 2017, the European Commission approved Lutathera peptide receptor radionuclide therapy (PRRT) drug manufactured by Advanced Accelerator Applications S.A. Although, the U.S. Food and Drug Administration (FDA) was approved LUTATHERA in January 2018. Growing clinical trials and development activities to create therapeutic radiopharmaceuticals expected to surge the growth of the peptide receptor radionuclide therapy (PRRT) market over the forecast period.

Peptide Receptor Radionuclide Therapy (PRRT) Market: Drivers and Restraints–

Increasing prevalence of the neuroendocrine tumors expected to impel the demand for peptide receptor radionuclide therapy (PRRT) as an increasing number of the patient pool. Establishment of reimbursement policies for Lutathera favors the demand for peptide receptor radionuclide therapy (PRRT). A temporary insurance/billing code was used for the peptide receptor radionuclide therapy (PRRT) till 2018. Moreover, increasing clinical trials for the new radiopharmaceuticals drugs approval for cancer therapy expected to surge the growth of the peptide receptor radionuclide therapy (PRRT) market.

Increasing government and private organizations funding for cancer drugs and therapy development is another major factor expected to propel the growth of the peptide receptor radionuclide therapy (PRRT) market. Moreover, growing manufacturer’s interest in the radiopharmaceutical and cancer market flourish the growth of the peptide receptor radionuclide therapy (PRRT) market. Side effects such as the transient decrease in blood counts, nausea and others associated with PRRT expected to hamper the growth of the peptide receptor radionuclide therapy (PRRT) market.

Peptide Receptor Radionuclide Therapy (PRRT) Market: Overview

Peptide receptor radionuclide therapy (PRRT) a special type of radiopharmaceutical which injected into the patients’ bloodstream. This radiopeptide travels and binds to neuroendocrine tumor cells and provide a high dose of radiation directly to the cancer cell. Big pharmaceutical market players are focusing to enter in the radiopharmaceutical market. For instance, In October 2017, Novartis AG acquired Advanced Accelerator Applications (AAA) for $3.9 billion to expand oncology portfolio. This acquisition was valuable for Lutathera radiopharmaceutical candidates which were under FDA review in 2018.

Peptide Receptor Radionuclide Therapy (PRRT) Market: Region-wise Outlook

North America and Europe region are expected to grebe more than half of the market share for peptide receptor radionuclide therapy. Increasing clinical trials for radiopharmaceuticals and growing demand for the targeted therapy for cancer are the major factors driving the growth of the peptide receptor radionuclide therapy market in the U.S. and European countries. The Asia pacific peptide receptor radionuclide therapy market expected to grow with significant growth rate as growing demand for advance treatment option and comparatively high prevalence of cancer in India and China.

A Full Report Overview

Key companies profiled:

  • Advanced Accelerator Applications (AAA) (Novartis AG)

Segments covered:

  • Indication,
  • End User,
  • Region

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Next Generation Infusion Pump Market Projected to Exceed USD 8,509 Million by 2032, Growing at a CAGR of 4.8%

Global Next Generation Infusion Pump Market
Global Next Generation Infusion Pump Market

The global next generation infusion pump market is set for significant growth, holding a forecasted market share of USD 5,059.7 million in 2022 and expected to surpass USD 8,509 million by 2032. This growth trajectory indicates a compound annual growth rate (CAGR) of 4.8% during the forecast period from 2022 to 2032.

Next generation infusion pumps are revolutionizing the administration of medications and fluids, enhancing the precision and efficiency of patient care. These advanced devices incorporate innovative technologies that enable healthcare professionals to deliver treatment with improved safety and accuracy, making them a vital component of modern medical practice.

Key drivers contributing to the growth of the next generation infusion pump market include:

  • Technological Advancements: The integration of smart technologies, including wireless connectivity, software updates, and automated drug delivery systems, is driving demand for next generation infusion pumps, improving patient outcomes and workflow efficiency.
  • Increasing Prevalence of Chronic Diseases: The rising incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is increasing the need for effective medication management and infusion therapies, propelling market growth.
  • Focus on Patient Safety: Growing emphasis on patient safety and the reduction of medication errors is leading healthcare providers to adopt advanced infusion systems equipped with safety features like dose error reduction systems and real-time monitoring capabilities.
  • Rising Demand for Home Healthcare: The shift towards home healthcare solutions is further enhancing the demand for portable and user-friendly infusion pumps, allowing patients to receive treatment in the comfort of their homes.

The technology used in regular infusion pumps hasn’t kept pace with advancements in healthcare industry. According a report published by institute of medicine in 2007, from year 2005 to 2009, 710 deaths and more than 56,000 adverse events were reported to FDA, most amongst medical technologies, adding more than $2 Bn to annual healthcare cost in US. On other hand Next Generation Infusion Pumps provide enough functionality, flexibility, scalability, affordability and ease of use needed to changing needs of healthcare system, indicating robust growth in Next Generation Infusion Pump market over the forecast period.

Next Generation Infusion Pumps attribute high integration between the pump and hospital IT system, reducing errors. Moreover, diverse new technologies like implantable insulin pumps in addition to delivering targeted, consistent medication, increases patient ease as well. The leading market players are focusing on safer operability, minimised chances of product recalls and enhanced product designs, over the forecast period.

Next Generation Infusion Pump Market: Drivers and Restraints

Insulin infusion pumps are dominating the Next Generation Infusion Pump market, however worldwide booming prevalence of diabetes is a key driver for Next Generation Infusion Pump market. Increased R & D initiatives on IV drug administration for malnutrition, cancers, diabetes, AIDS, neurological disorders, gastrointestinal disorders coupled with technological innovation, is anticipated to generate lucrative growth in Next Generation Infusion Pump market.

The regular infusion pump market has observed massive bad press in last few years, for diverse risk and concerns over infusion errors, this restraint however, has opened multiple opportunities for Next Generation Infusion Pump manufacturers. Furthermore, lack of sufficient healthcare infrastructure in developing markets is anticipated to impact negatively on Next Generation Infusion Pump market.

Next Generation Infusion Pump Market: Overview

Next Generation Infusion Pump market is emerging owing to promising discovery of new innovative pumps. Key players in market are focusing on new technologies such as smartphone connected insulin pumps, wearable insulin pumps and implantable insulin pumps, also focusing on accessing secure and immediate access to patient specific infusion pump management information from any mobile device or computer, regardless of Electronic Medical Record integration. Such R&D improvements are making a ground-breaking infusion management platform, indicating transformation in Next generation Infusion Pump Market.

Next Generation Infusion Pump Market: Region-wise Outlook

Geographically, next generation infusion pump market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe regions are anticipated to contribute maximum market revenue share in Next generation infusion pump market over the forecast period due to availability of advanced healthcare infrastructure and presence of key players in the regions which are expected to surge the demand for next generation infusion pumps during the forecast period in the above mentioned region. Asia Pacific region as well, is anticipated to witness crucial growth due to growing healthcare infrastructure in the region. Increasing number of mid-sized hospitals are identified to be a major driver to the APEJ market growth.

Next Generation Infusion Pump Market: Key Players

The players leading in next generation infusion pump market include Ivenix, Inc, Zyno medical, B. Braun Melsungen AG, Baxter International, Inc.,F. Hoffmann-la Roche Ltd.,Johnson & Johnson (U.S.),Pfizer (Hospira) Inc., Smiths Medical to name a few.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

A Full Report Overview

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil and Rest of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
  • Eastern Europe (Poland, Russia and Rest of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Next Generation Infusion Pump Market: Segmentation

Next Generation Infusion Pump market has been segmented on the basis of application, end user, and region

Based on Application, the Next Generation Infusion Pump market is segmented into the following:

  • Oncology
  • Analgesia
  • Diabetes
  • Hematology
  • Neonatology
  • Gastroenterology
  • Autoimmune Diseases

Based on end user, the Next Generation Infusion Pump market is segmented into the following:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Clinics
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Newborn Eye Imaging Systems Market to Reach USD 374.3 Million by 2032, Growing at a CAGR of 5.7%

Global Newborn Eye Imaging Systems Market
Global Newborn Eye Imaging Systems Market

The global newborn eye imaging systems market is projected to experience significant growth, with a forecasted valuation of USD 374.3 million by 2032, up from USD 202.7 million in 2022. This growth represents a compound annual growth rate (CAGR) of 5.7% during the forecast period.

As advancements in pediatric healthcare continue to evolve, the demand for innovative eye imaging systems specifically designed for newborns is on the rise. These systems play a crucial role in the early detection and diagnosis of eye-related conditions, which can significantly impact a child’s overall development and quality of life.

Key factors driving the growth of the newborn eye imaging systems market include:

  • Rising Awareness of Neonatal Eye Health: Increased awareness among healthcare providers and parents regarding the importance of early eye screenings for newborns is propelling the demand for specialized imaging systems.
  • Technological Advancements: Continuous advancements in imaging technologies are leading to the development of more efficient and user-friendly systems, enhancing diagnostic capabilities and patient outcomes.
  • Growing Incidence of Eye Disorders: The rising prevalence of eye disorders among newborns, including retinopathy of prematurity (ROP) and congenital cataracts, is driving the need for effective imaging solutions.
  • Investment in Pediatric Healthcare: Increasing investments in pediatric healthcare infrastructure and research are facilitating the growth of the newborn eye imaging systems market, providing enhanced access to advanced diagnostic tools.

Eye imaging systems play a pivotal role in identifying and addressing ocular issues, with a strong focus on ophthalmic concerns. The global population is grappling with a substantial burden of eye disorders. Notably, in newborns, Retinopathy of Prematurity (ROP) emerges as a leading cause of vision impairment. ROP also impacts the blood vessels and spreads within the retina.

In light of these developments, the eye imaging technology sector is poised for a significant transformation, catering to the burgeoning demand for advanced diagnostics and treatment options. With a CAGR of 5.7%, the industry is primed to provide cutting-edge solutions to enhance vision and address eye health concerns.

New Born Eye Imaging Systems Industry: Drivers and Restraints

The New born eye imaging is an emerging market, as many players are coming with innovative devices for imaging and raising the funds for research on new born eye imaging system, for instance, in May 2017, Visunex Medical Systems, Inc., has raised fund of USD$ 20 Mn for the research and development and manufacturing of new born eye imaging system. Players are actively participating in development of imaging systems.

The ratio of effected born babies are also fuel the market to come with more advance products in the market, for instance, according to WebMD, LLC., 16,000 from 28,000 born babies are affected from ROP (retinopathy of prematurity) as the babies will be born less than 31 weeks and the weight will be more than 2 pounds in the U.S, The awareness is the hindrance for the product.

New Born Eye Imaging Systems Industry: Overview

New born eye imaging system is a growing market over the forecast period, as many product are coming in the market after getting approval from respective organization, all the product are in high demand for imaging, for instance, in March 2012, Russia’s third president has approved the purchase of new born eye imaging system from Clarity Medical Systems, Inc., and launched RetCam digital imaging program in Russian Federation for the treatment of prematurely born infants at risk for eye diseases like ROP (retinopathy of prematurity).

New Born Eye Imaging Systems Industry: Region-wise Outlook

Geographically, the New Born Eye Imaging Systems Industry Market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa.

North America is the leading market as major players are placed inside and the number of population effected with new eye problem, for instance according to Centers for Disease Control and Prevention in October 2016, one in every 33 babies are affected from eye born diseases. Europe is also potential market as government are directly involved in treatment of eye diseases. Asia Pacific is a growing market as the awareness is very less in the market about this system.

New Born Eye Imaging Systems Industry: Key Players

Some players in the New Born Eye Imaging Systems Industry Market include Visunex Medical Systems, Inc., Eye Photo Systems, Merge Healthcare Incorporated, D-EYE S.r.l., Imagine Eyes, Natus Medical Incorporated and Servicom Medical (Singapore) Pte Ltd.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil and Rest of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
  • Eastern Europe (Poland, Russia and Rest of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

A Full Report Overview

New Born Eye Imaging Systems Industry: Segmentation

New Born Eye Imaging System segmentation is based on

Based on diseases type

  • Retinopathy of prematurity
  • Ocular development
  • Refractive state
  • Strabismus
  • Visual functions
  • Visual acuity
  • Visual fields
  • Colour vision

Based on Device Type

  • Basic Device
  • Wireless Device

Based on End User

  • Hospital
  • Ophthalmology Diagnosis Centre
  • Ambulatory Surgical Centre
  • Others

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Industrial Power Supply Market Size Anticipated to Exceed USD 21.5 Billion by 2034, Growing at 10.1% CAGR | FMI Study

The industrial power supply market is estimated to be worth USD 8.2 billion in 2024 and is projected to be valued at USD 21.5 billion in 2034. Between 2024 and 2034, the industry is poised to rise at a CAGR of 10.1%. The growing integration of industrial automation and the implementation of Industry 4.0 initiatives are contributing to a heightened demand for dependable and efficient power supplies. This demand stems from the necessity of providing stable and accurate power delivery to automation systems, encompassing PLCs, robotics, and control systems.

The increasing recognition of the importance of energy conservation and sustainability in industrial settings is fostering a preference for energy-efficient power supplies. Businesses are actively seeking power solutions that not only optimize energy consumption but also contribute to reducing overall operational costs. Global economic growth and the expansion of manufacturing and industrial infrastructure contribute to increased demand for power supplies. As industries expand, there is a need for reliable and scalable power solutions to support new facilities and equipment.

Browse Full Report Here

Continuous technological progress, marked by enhancements in power electronics, digital control, and the integration of intelligent features, propels the evolution of highly efficient and advanced industrial power supplies. To remain competitive in this dynamic market, companies are dedicating resources to research and development initiatives.

Key Takeaways from the Market Study:

  • From 2019 to 2023, the industrial power supply market expanded at a CAGR of 13.2%.
  • Based on the product types, the AC-DC converters segment is expected to rise at a CAGR of 9.8% from 2024 to 2034.
  • The industrial power supply demand in China is predicted to grow at a CAGR of 9.2% through 2034.
  • In the United States, the industrial power supply industry is estimated to register a CAGR of 10.4% from 2024 to 2034.
  • The United Kingdom is projected to expand by a value CAGR of 10.8% between 2024 and 2034.
  • The industrial power supply market in Japan is anticipated to record a CAGR of 11.5% during 2034.

“The industrial power supply market is experiencing momentum driven by the growth of manufacturing and industrial infrastructure, coupled with a rising demand for energy-efficient solutions in industrial settings.” says Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.).

Competitive Landscape:

The industrial power supply market players are forming strategic partnerships with other industry players, technology providers, or manufacturers to enhance product portfolios or expand market reach and collaborating with key stakeholders in the supply chain to ensure a seamless and reliable power supply ecosystem.

Leading Manufactures in Industrial Power Supply Market:

  • TDK Lambda
  • Delta Electronics
  • XP Power
  • Siemens
  • Murata Power Solutions
  • Advanced Energy
  • Bel Fuse
  • Cosel
  • MEAN WELL

Recent Developments in Industrial Power Supply Industry:

  • TDK Lambda – a leading global manufacturer of power supplies, TDK Lambda specializes in providing innovative and reliable solutions for various industrial applications.
  • Delta Electronics – is a multinational company known for its power and thermal management solutions, offering a wide range of industrial power supply products.
  • XP Power – is a well-established provider of power solutions, delivering high-quality and efficient power supplies for industrial applications, including medical, technology, and industrial sectors.

Industrial Power Supply Market Segmentation Analysis:

By Product Types:

  • AC-DC Converters
  • DC-DC Converters

By Output Power:

  • Very Low Output (Up to 500W)
  • Low Output (500W-1,000W)
  • Medium Output (1,000W-10 kW)
  • High Output (10-75kW)
  • Very High Output (75-150kW)

By Vertical:

  • Transportation
  • Semiconductor
  • Military & Aerospace
  • Robotics
  • Test & Measurement
  • Battery Charging & Test
  • Industrial 3D Printing
  • Laser
  • Lighting

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa

Browse Related Reports:

The below 30 Hp centrifugal water pump market is anticipated to reach USD 68.95 million in 2032.

The global heat pump market is anticipated to secure a valuation of USD 58.7 billion by 2033.

The global heavy-duty heat pump market is likely to secure USD 4.8 billion in 2033.

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Commercial Water Heater Market Revenue Share to Cross USD 16 Billion Mark by 2034, Growing at 6.9% CAGR | FMI Study

According to Future Market Insights (FMI), the commercial water heater market is estimated to be worth USD 8.2 Billion in 2024 and is projected to be valued at USD 16 Billion in 2034. Between 2024 and 2034, the industry is expected to register a CAGR of 6.9%. Economic growth and increased construction activities, particularly in commercial sectors such as hospitality, healthcare, and manufacturing, drive the demand for water heaters. New commercial buildings, hotels, and industrial facilities require reliable hot water solutions to drive market growth.

Global urbanization trends result in the construction of more commercial spaces, contributing to a heightened demand for water heaters. Urban areas witness increased commercial development, necessitating efficient water heating solutions for various applications. Businesses are placing greater importance on energy efficiency and sustainability. Modern commercial water heaters come with advanced technologies and features that enhance energy efficiency, reduce operational costs, and align with environmentally friendly practices.

Browse Full Report Here

The demand for commercial water heaters in various industries, including hospitality, healthcare, education, manufacturing, and food service is expected to propel the market growth. Each industry has specific hot water requirements, driving the need for specialized water heating solutions. The growth of the food service and hospitality sectors, including restaurants, hotels, and catering services, contributes significantly to the demand for commercial water heaters. These establishments rely on hot water for various purposes, such as cooking, cleaning, and guest amenities.

The heightened awareness of hygiene and sanitization, especially in industries like healthcare and food service, has led to a greater demand for hot water. Commercial water heaters play a crucial role in providing the necessary hot water for cleaning and sanitizing purposes. The growth of the global tourism industry contributes to increased demand for commercial water heaters in hotels, resorts, and other accommodations. The hospitality sector, driven by tourism, relies heavily on efficient water heating systems.

Key Takeaways from the Market Study:

  • From 2019 to 2023, the commercial water heater market expanded at a CAGR of 8.6%.
  • Based on storage capacity, the below 500 L segment is expected to rise at a CAGR of 6.6% from 2024 to 2034.
  • The commercial water heater demand in China is predicted to grow at a CAGR of 7.7% through 2034.
  • In the United States, the commercial water heater industry is estimated to register a CAGR of 7.2% from 2024 to 2034.
  • The United Kingdom is projected to expand by a value CAGR of 8.1% between 2024 and 2034.
  • The commercial water heater market in Japan is anticipated to record a CAGR of 8.0% during 2034.

“The, commercial water heater market is experiencing substantial growth due to the expanding footprint of the hospitality sector and a heightened focus on improving energy efficiency.” – opines Nikhil Kaitwade, Associate Vice President at Future Market Insights (FMI).

Competitive Landscape:

The market players are adapting strategies to cater to the specific needs and preferences of diverse consumer bases. Market players are actively forming strategic alliances, entering into partnerships, and pursuing mergers and acquisitions to propel technology development. Manufacturers are increasingly offering customized and specialized commercial water heating solutions to meet the unique needs of different industries.

Key Players Profiled in the Report:

  • A.O. Smith
  • Rinnai Corporation
  • Rheem Manufacturing
  • Ariston Thermo S.p.A
  • Racold
  • Midea Group
  • Nibe Corporation
  • Nortiz Corporation
  • Hubbell
  • Valliant
  • Lowe’s
  • Bradford White Corporation
  • Flexiheat UK Ltd
  • Daikin Industries

Recent Developments:

  • Racold, a brand of Ariston Thermo, is a major player in the Indian market. They manufacture a wide range of water heating solutions, including commercial water heaters.
  • Midea Group, based in China, is a leading global manufacturer of home appliances and HVAC systems. They offer a diverse range of products, including commercial water heaters.

Commercial Water Heater Market Segmentation Analysis:

By Storage Capacity:

  • Below 500 L
  • 500-1000 L
  • 1000-2000 L
  • 2000-3000 L
  • More than 3000 L

By Power Rating:

  • 0 to 10 kW
  • 10 to 50 kW
  • 50 to 100 kW
  • 100 to 300 kW
  • 100 to 300 kW

By Fuel Type:

  • Electric
  • Gas
  • Oil
  • Solar
  • Hybrid
  • Others

By Application:

  • Healthcare
  • Restaurants
  • Institutes
  • Offices
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa

Browse Related Reports:

The global industrial solar water heaters market share to surpass USD 1,138.9 million by 2032.

The global produced water treatment system industry anticipated to cross USD 8.41 billion valuation by 2034.

The global chilled water storage system market revenue forecasted to reach USD 322.9 million mark in 2033.

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Miter Saw Market Revenue Share Estimated to Cross USD 1,788.50 Million by 2034, Growing Steadily at 4.80% CAGR | FMI Study

The global miter saw market value is expected to rise from USD 1,087.6 million in 2024 to USD 1,788.50 million by 2034. This estimated growth is expected to be driven by a moderate CAGR of 4.80% in the miter saw market over the next decade.

Home renovation and DIY projects are increasing across the globe. With rising investments to elevate living spaces, miter saw sales consistently grow. Surging home improvement projects, spurred by a desire to personalize private spaces, enhance the market scope. The growth in manufacturers that develop convenient miter saws and give professional-level results is pushing the market growth.

The increasing affordability of complex power tools is further contributing to the product’s demand. Additionally, efforts to bring manufacturing efficiencies and technological advancements have contributed to increasing the accessibility of miter saws to a broader customer base. In addition to this, the growing wealth of online tutorials that demystify the use of milter saw is supporting investments in milter saw for crafting projects.

Browse Full Report Here

The use of advanced technological features in milter saws and consistent demand to enhance the experience of construction activities are projected to uplift sales of milter saws in upcoming years.

“Key players are working on product affordability and versatility to boost its adoption among the wide-scale population. Additionally, players are expected to find significant growth in emerging economies where construction projects can be implemented,” – Says Nikhil Kaitwade, Associate Vice President at Future Market Insights, Inc.

Key Takeaways from the Miter Saw Market Report:

  • Europe acquired a market share of 26%, whereas North America captured a market share of 23% in 2023.
  • The United States is expected to register a CAGR of 4.4% in North America through 2034.
  • Europe, Germany, and the United Kingdom are anticipated to attain CAGRs of 4.2% and 4.4%, respectively, through 2034.
  • In Asia Pacific, recent estimates display India to record 5.5% CAGR and China to register 5.3% CAGR through 2034.
  • Woodworking is a leading end user of milter saw, which attained a 24% market share in 2023.
  • Benchtop is a significantly requested product type, which acquired a market share of 27% in 2023.

Strategies Employed by Leading Players Operating in the Milter Saw Market:

Milter saw players concentrating on gaining high-value acquisitions to further their motive of capturing a larger market share. Key players are launching advanced products and employing strategies like collaborations, partnerships, and mergers to increase market penetration.

Players are leaving no stone unturned in increasing their market presence by using their social media presence and employing different marketing campaigns. Additionally, they are strengthening their distribution channels to reach customers far and wide.

Key Players Operating in the Miter Saw Market:

  1. CR Laurence
  2. DeWalt
  3. Craftsman
  4. Genesis
  5. Hitachi
  6. Makita
  7. Festool
  8. Bosch
  9. Chicago Pneumatic
  10. Jet
  11. TruePower
  12. ATE Tools
  13. Others

Global Miter Saw Market Segmentation:

By Product Type:

  • Basic
  • Benchtop
  • Compound
    • Single Bevel
    • Dual Bevel
  • Sliding
  • Others (if any)

By Mobility:

  • Corded
  • Cordless

By Power Capacity:

  • Up to 1000 Watts
  • 1000 to 1500 Watts
  • 1500 to 2000 Watts
  • Above 2000 Watts

By End Use:

  • Domestic
  • DIY Tasks
  • Arts & Crafts
  • Professional
    • Woodworking & Furniture
    • Metal Fabrication
    • Construction & Flooring Solution
    • Others
  • MRO Services
    • Automotive
    • Marine
    • Aerospace
    • Other Industrial

By Sales Channel:

  • Direct
  • Indirect
    • Online
    • Distributors
    • DIY Stores

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific Except Japan
  • Japan
  • The Middle East and Africa

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Bead Winding Machine Market Revenue Forecasted to Surge Past USD 1,281.70 Million Mark by 2034, Growing Steadily at 2.5% CAGR

The global bead winding machine market is predicted to capture a valuation of USD 972.4 million in 2024 with a CAGR of 2.50% during the forecast period. The global market is anticipated to secure a valuation of USD 1,281.70 million by 2034.

Manufacturers are adopting intelligent and cutting-edge technology to develop automatic bead winding machines for making highly efficient tires that attract end users’ requirements. These manufacturers are innovative new ideas and collaborate with essential players to gain knowledge, strategies, and ideas to fuel the market growth.

Increasing consumer demand for high-performance vehicles and motors significantly increases the adoption of bead winding machines. The rising requirements for enhancing the production processes faster are surging the demand for bead winding machines in the automotive sector. Rising highly skilled workers ensure these devices’ safety, quality, and performance, significantly fuel the market growth.

Browse Full Report Here

Manufacturers are focused on maintaining quality by adopting stringent regulations, which are gaining popularity among consumers. The demand for automatic bead winding is increasing for flexible and off-road driving experiences. These manufacturers integrated various advanced technologies such as the Internet of Things and advanced sensors to enhance the machine’s efficiency to work faster and more conveniently.

Consumers seeking fuel efficiency, seamless work, and sustainable practices are raising the global market revenue. These consumers are looking for premium and luxury cars that significantly boost the sales of the bead winding machine market.

“The growing popularity of multi-wire bead winding machines due to automatic process control is expanding the market growth. Innovation in bead winding machine is bringing cost-effective solutions and reduced labor workload to offer premium quality with sizable production.” opines Nikhil Kaitwade, Associate Vice President at Future Market Insights (FMI).

Key Takeaways:

  • The bead winding machine market is registering a CAGR of 2.50% between 2024 and 2034.
  • The United States is expected to register a CAGR of 2.10% by dominating the global market by 2034.
  • India is anticipated to capture a CAGR of 3.20% of the global market in 2034.
  • Germany is anticipated to register a CAGR of 1.90% in the global market in 2034.
  • China significantly drives the global market with a CAGR of 3.0%.
  • With a CAGR of 2.10%, the United Kingdom is rapidly advancing globally.
  • The single-bead category is estimated to lead the global market during the forecast period.
  • Passenger cars are likely to register a maximum share of the global market by 2034.

Key Players in the Bead Winding Machine Market:

The global market is highly fragmented by crucial players that develop cost-effective, durable, and excellent automotive tires and other components. These players are adopting sustainable practices to build these devices, gaining vast popularity in the market. Key players bring innovative and intelligent ideas to expand the market size. They visit numerous events, exhibitions, shows, festivals, and online platforms to highlight their brand identity.

These players are adopting various marketing methodologies to gain market revenue, including collaboration and mergers. Key players are taking customer feedback to maintain product transparency and boost sales. These players are the backbone of businesses that innovate multiple ideas and thousands of innovations to stay ahead of competitors.

The Top Key Players in the Bead Winding Machine Market:

  • Bharaj Machineries Pvt Ltd
  • VMI Group
  • Kobe Steel, Ltd
  • Tianjin Saixiang Technology Co, Ltd
  • Herbert Maschinenbau GmbH & Coo. KG
  • Cimcorp
  • Lorenz Pan AG
  • MEC A/S
  • Strongman Group

Key Segments Covered in the Bead Winding Machine Market:

By Configuration:

  • Single Bead
  • Multi-spinder Bead
  • Automatic Bead
  • CNC Bead
  • High-speed Bead

By Application:

  • Passenger Cars
  • Commercial Vehicles
  • Off-road Vehicles
  • Industrial Machinery
  • Agriculture Machinery

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Internal Gear Pump Market Analysis States the Industry to Reach USD 857.2 Million by 2034, Driven by 4.2% CAGR Growth

The internal gear pump market is worth USD 529.1 Million in 2023. The demand for internal gear pumps is expected to surge at a CAGR of 4.2% over the forecast periods. The global internal gear pump industry is estimated to reach USD 857.2 Million by 2034, rising from USD 552 Million in 2024.

The internal gear pump industry is being propelled by several key drivers that underscore its significance in various sectors. One notable driver is the increasing demand for efficient and reliable pumping solutions across industries such as oil and gas, chemicals, and automotive.

Internal gear pumps are lauded for their ability to handle diverse fluids with precision, making them a preferred choice in applications requiring consistent and controlled flow rates. Additionally, advancements in technology, including the integration of smart sensors and monitoring systems, enhance the performance and reliability of internal gear pumps, further driving their adoption in critical processes.

Browse Full report Here

The internal gear pump industry is poised for growth with promising opportunities on the horizon. As industries increasingly prioritize sustainability, the inherent design advantages of internal gear pumps, such as their ability to handle viscous fluids and offer precise metering, position them as environmentally friendly alternatives. Moreover, the rising focus on process optimization and energy efficiency presents an avenue for the internal gear pump industry to thrive.

Key Takeaways from the Global Internal Gear Pump Market Study Report:

  • The United States enjoys the presence of some leading internal gear pump manufacturers, and the market is expected to advance at a 3.8% CAGR through 2024.
  • In Europe, the United Kingdom is currently leading the market, with sales of internal gear pumps projected to progress at a 3.8% CAGR through 2024.
  • China is the leading manufacturer of internal gear pumps in Asia, and the market is anticipated to follow a 4.7% CAGR through 2034.
  • The market in India is expected to witness lucrative industrial growth at 4.9% CAGR through 2034.

“The higher adoption of gear pumps due to their better resistance to abrasive or corrosive fluid drives their demand in various industries. The integration of automation and smart control features with hydraulic gear pumps has also increased its attractiveness industries purposes in recent years,” – opines Nikhil Kaitwade, Associate Vice President at Future Market Insights (FMI).

Competitive Landscape in the Internal Gear Pump Market:

The global hydraulic internal gear pump market has turned highly fragmented and competitive after the emergence of many regional manufacturers in the last few years. Advanced industrial technologies are now accessible to equipment manufacturers across all countries after globalization which is driving the growth of regional players.

Recent Developments by the Internal Gear Pump Manufacturing Industries:

  • In April 2021, EnviroGear company introduced its E Series magnetically coupled seal-less internal gear pumps. It is an eco-friendly, long-lasting positive displacement pump with an inventive design that efficiently stops leaks and minimizes mechanical wear, improving both the environment’s and site workers’ safety. Also, with its unique between-the-bearing support mechanism, it stands out from the competition based on its superior manufacturing and short lead times.
  • In May 2021, Eckerle company developed an EIPC internal gear high-pressure pump created specifically for use in injection molding machine technology. This innovative product can be used in speed-regulated fixed hydraulic functions that are run at set pressures of as high as 250 bar. Along with a great price-to-performance ratio for systems where cost factor is a key consideration, it also has an extended lifespan and operates with minimum sound and vibration. The company also claims the Eckerle EIPC industrial pump can tolerate a high peak pressure of up to 320 bar and is simple to pair up to produce many pumps.

Key Players Operating in the Global Internal Gear Pump Industry:

  • Bosch Rexroth
  • Sumitomo Precision
  • Viking Pump
  • Dover
  • NOP
  • Voith
  • Tuthill
  • Yuken
  • SPX FLOW
  • Bucher Hydraulics
  • Haight Pumps
  • Hydac International
  • Daido Machinery
  • HSP
  • Shangai Heshan Pump
  • Taibang
  • Chongqing Huanzhou Pumps
  • Hannuo Pump

Internal Gear Pump Market Segmentation Analysis:

By Product Type:

  • Steel Pumps
  • Cast Iron Pumps
  • Other Pumps
  • Heavy-duty Pumps

By End-use Industry:

  • Chemical Industry
  • Marine Industry
  • Oil & Gas Sector
  • Food & Beverage Companies
  • Other End-use Applications

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia and Pacific
  • Middle East and Africa (MEA)

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Myelodysplastic Syndrome Treatment Market Set to Reach USD 5,614.1 Million by 2032, Growing at a CAGR of 5.9%

Global Myelodysplastic Syndrome Treatment Market
Global Myelodysplastic Syndrome Treatment Market

The global myelodysplastic syndrome (MDS) treatment market is on track to experience substantial growth, with a projected compound annual growth rate (CAGR) of 5.9%. The market generated a revenue share of approximately USD 2,990.8 million in 2022 and is expected to reach around USD 5,614.1 million by 2032.

Myelodysplastic syndromes, a group of diverse bone marrow disorders characterized by ineffective blood cell production, have seen increased attention in recent years due to a rising patient population and advancements in treatment options. As awareness and understanding of MDS grow, healthcare providers are increasingly focusing on improving patient outcomes through innovative therapies.

Key factors contributing to the anticipated growth of the MDS treatment market include:

  • Rising Incidence of MDS: The prevalence of myelodysplastic syndromes is on the rise, particularly among the aging population, which is driving demand for effective treatment options.
  • Advancements in Treatment Options: Ongoing research and development in pharmacological therapies, including novel agents and combination treatments, are enhancing the management of MDS, providing patients with improved survival rates and quality of life.
  • Increasing Investment in Healthcare: Growing investments in healthcare infrastructure and oncology research are facilitating the development and accessibility of advanced therapies for MDS.

Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow are damaged. This damage leads to low numbers of one or more type of blood cells. MDS is considered as a type of cancer.

Myelodysplastic syndromes are a rare group of disorders in which body no longer makes enough healthy blood cells. This disorder can also be called as “bone marrow failure disorder.”

The patient pool are more of age group of 50 or older, but it can happen to younger people, too. This syndrome is more common in men as compared to women.

According to American Society of Clinical Oncology (ASCO), approximately 13,000 people in the U.S. are diagnosed with MDS each year.

Myelodysplastic Syndrome Treatment Market: Drivers and Restraints

The Myelodysplastic Syndrome Treatment market is expected to mark a significant growth in the coming few years due to increasing mutation in treatments which cause myelodysplastic syndrome. Addition to this, growing number of patient pool of age 50 and above, and rising government support for cancer treatment tend to propel the market.

However, unawareness about such treatments is one of the major factor which is delaying the growth of this market.

Myelodysplastic Syndrome Treatment Market: Overview

The global market for myelodysplastic syndrome treatment is expected to witness high growth over the forecast period due increasing incidences of myelodysplastic syndrome. In the U.S., myelodysplastic syndromes (MDS) occur at a rate of 4.8 cases for every 100,000 people. That works out to about 13,000 new cases of MDS each year. The number of new cases diagnosed each year seems to be increasing as the average age of the population increases. (Source: American Cancer Society).

Furthermore, diagnosis techniques such as blood count, peripheral blood smear test, microscopic exams, cytochemistry, flow cytometry and immunotherapy, cytogenetics, FISH, and PCR help in the detection of MDS, also key factor which is propelling the myelodysplastic syndrome treatment market towards growth.

Myelodysplastic Syndrome Treatment Market: Regional Outlook

Geographically, global myelodysplastic syndrome treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America and Europe together dominates the global myelodysplastic syndrome treatment market due to presence of large number of population suffering from bone marrow disease, rise in healthcare expenditure, and increasing demand for myelodysplastic syndrome treatment by the end users. Asia Pacific myelodysplastic syndrome treatment market is expected to be one of the fastest growing markets due to increasing number of patient with blood marrow disorder.

Myelodysplastic Syndrome Treatment Market: Key Players

The market for myelodysplastic syndrome treatment is consolidated with a presence of few strong players. Some of the players identified in global myelodysplastic syndrome treatment market include Celgene Corporation, Otsuka Holdings Co., Ltd., Sandoz, Inc., Dr. Reddy’s Laboratories, Inc., Accord Healthcare Ltd., Mylan N.V., Pfizer, Inc. etc.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, South Africa, Rest of MEA)

A Full Report Overview

Myelodysplastic Syndrome Treatment Market: Segmentation

Tentatively, global myelodysplastic syndrome treatment market has been segmented on the basis of types, treatments, patient group, and geography

Based on Type, global myelodysplastic syndrome treatment market is segmented as below:

  • Refractory cytopenia with unilineage dysplasia (RCUD)
  • Refractory anemia with ringed sideroblasts (RARS)
  • Refractory cytopenia with multilineage dysplasia (RCMD)
  • Refractory anemia with excess blasts-1 (RAEB-1)
  • Refractory anemia with excess blasts-2 (RAEB-2)
  • Myelodysplastic syndrome, unclassified (MDS-U)
  • Myelodysplastic syndrome associated with isolated del(5q)

Based on treatment, global myelodysplastic syndrome treatment market is segmented as below:

  • Chemotherapy
  • Immunotherapy
  • Stem cell transplantation / bone marrow transplantation
  • Growth Factors

Based on patient group, global myelodysplastic syndrome treatment market is segmented as below

  • Above 50 years
  • Below 50 years

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube